Sparse Securities Claims Against COVID-19 Treatment Maker Again Dismissed

Mealey's (April 12, 2022, 1:33 PM EDT) -- SAN DIEGO — Dismissal of shareholder claims in a securities class action lawsuit against a clinical-stage biopharmaceutical company and certain of its senior executives stemming from alleged misrepresentations the defendants made...
To view the full article, register now.